tiprankstipranks
National Healthcare Properties (HLTC)
OTHER OTC:HLTC
US Market
Want to see HLTC full AI Analyst Report?

National Healthcare Properties (HLTC) AI Stock Analysis

30 Followers

Top Page

HLTC

National Healthcare Properties

(OTC:HLTC)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 5.2)
Rating:54Neutral
Price Target:
$11.50
▼(-9.09% Downside)
Action:Reiterated
Date:08/06/26
HLTC’s score is held back primarily by persistently negative net profitability and uneven cash-flow history, despite a recent TTM cash-flow rebound and mixed leverage data quality. Technicals are moderately positive with price holding above key longer-term moving averages and positive MACD. Valuation is unattractive on reported metrics due to a negative P/E and no dividend yield, while recent corporate actions (credit facility restructuring and preferred redemptions/tenders) modestly improve the outlook through better balance-sheet flexibility.
Positive Factors
Credit facility upsized
Upsizing and extending a $1.2B unsecured facility with delayed-draw capacity, longer maturities and spreads tied to leverage materially raises liquidity and reduces near-term refinancing risk. This durable funding flexibility supports growth, acquisitions and smoother debt maturities over the next 2–6 months.
Negative Factors
Negative GAAP profitability
Persistent GAAP losses and negative ROE indicate the company isn’t generating bottom-line returns on shareholder capital. Even with positive property-level EBITDA, ongoing net losses constrain retained earnings, limit reinvestment or distributions, and can impede long-term balance-sheet repair.
Read all positive and negative factors
Positive Factors
Negative Factors
Credit facility upsized
Upsizing and extending a $1.2B unsecured facility with delayed-draw capacity, longer maturities and spreads tied to leverage materially raises liquidity and reduces near-term refinancing risk. This durable funding flexibility supports growth, acquisitions and smoother debt maturities over the next 2–6 months.
Read all positive factors

National Healthcare Properties (HLTC) vs. SPDR S&P 500 ETF (SPY)

National Healthcare Properties Business Overview & Revenue Model

Company Description
National Healthcare Properties, Inc. is a real estate investment trust for U.S. federal income tax purposes. The Company acquires, owns and manages a diversified portfolio of healthcare-related real estate, focused on outpatient medical facilities...

National Healthcare Properties Financial Statement Overview

Summary
Overall financial quality is below average. Profitability remains weak with negative net income across annual periods and TTM, despite generally positive EBITDA margins. Cash flow is improving with positive TTM operating cash flow and free cash flow, but multi-year volatility and sharply negative TTM FCF growth reduce confidence in sustainability. Balance sheet signals are mixed, including inconsistent TTM debt reporting and persistently negative ROE.
Income Statement
28
Negative
Balance Sheet
52
Neutral
Cash Flow
45
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue85.87M339.81M353.79M345.93M335.85M329.36M
Gross Profit-249.91M-33.14M132.65M128.13M122.40M123.54M
EBITDA162.04M82.02M-22.36M76.87M53.76M42.59M
Net Income-73.81M-71.07M-189.70M-72.30M-79.62M-85.18M
Balance Sheet
Total Assets1.70B1.71B1.95B2.15B2.18B2.21B
Cash, Cash Equivalents and Short-Term Investments52.81M57.62M21.65M46.41M53.65M59.74M
Total Debt1.05B380.95M1.15B1.18B1.12B1.09B
Total Liabilities1.10B1.11B1.26B1.24B1.18B1.17B
Stockholders Equity592.16M600.06M684.56M894.15M992.64M1.03B
Cash Flow
Free Cash Flow8.87M-21.77M-101.75M-773.00K302.00K19.81M
Operating Cash Flow37.19M6.95M-79.85M21.62M28.30M38.88M
Investing Cash Flow-13.66M69.81M63.97M-62.82M-41.78M-47.92M
Financing Cash Flow-43.35M-42.40M-1.35M55.97M4.64M4.08M

National Healthcare Properties Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price12.65
Price Trends
50DMA
10.36
Positive
100DMA
9.22
Positive
200DMA
8.46
Positive
Market Momentum
MACD
0.56
Positive
RSI
48.77
Neutral
STOCH
68.89
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLTC, the sentiment is Neutral. The current price of 12.65 is above the 20-day moving average (MA) of 11.54, above the 50-day MA of 10.36, and above the 200-day MA of 8.46, indicating a neutral trend. The MACD of 0.56 indicates Positive momentum. The RSI at 48.77 is Neutral, neither overbought nor oversold. The STOCH value of 68.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HLTC.

National Healthcare Properties Risk Analysis

National Healthcare Properties disclosed 86 risk factors in its most recent earnings report. National Healthcare Properties reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

National Healthcare Properties Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$523.15M162.044.96%10.14%5.24%
62
Neutral
$190.93M22.2261.18%4.55%24.57%7.81%
57
Neutral
$602.48M31.0112.79%6.80%0.75%7.29%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
54
Neutral
$362.17M-205.68-11.41%0.00%-2.13%51.61%
54
Neutral
$2.15B-6.70-16.22%0.43%0.39%-8.95%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HLTC
National Healthcare Properties
12.00
4.15
52.87%
DHC
Diversified Healthcare Trust
8.72
5.35
158.98%
CHCT
Community Healthcare
15.58
1.90
13.91%
UHT
Universal Health Realty Income
42.07
6.78
19.22%
STRW
Strawberry Fields REIT Inc
14.44
4.90
51.28%

National Healthcare Properties Corporate Events

Business Operations and StrategyExecutive/Board ChangesFinancial DisclosuresPrivate Placements and Financing
National Healthcare Properties Redeems Preferred Shares, Optimizes Capital
Positive
Aug 5, 2026
In the second quarter of 2026, National Healthcare Properties completed its transition to the public markets, reporting a net loss of $0.13 per share but steady FFO per share, alongside 6.8% same-store cash NOI growth and a standout 20.1% increase...
Regulatory Filings and Compliance
National Healthcare Properties Addresses Recent Mini-Tender Offer
Neutral
Jun 16, 2026
National Healthcare Properties, Inc. disclosed that on June 15, 2026, MacKenzie Capital Management launched an unsolicited mini-tender offer to acquire up to 150,000 shares, about 0.2% of NHP’s outstanding common stock, at $7.27 per share, a...
Business Operations and StrategyStock Buyback
National Healthcare Properties Launches Preferred Share Tender Offers
Positive
May 18, 2026
On May 18, 2026, National Healthcare Properties launched concurrent tender offers to repurchase up to $100 million of its 7.375% Series A and 7.125% Series B cumulative redeemable perpetual preferred shares at $22.50 per share in cash. The offers,...
Executive/Board ChangesShareholder Meetings
National Healthcare Properties Shareholders Approve Directors and Governance Items
Neutral
May 15, 2026
At its May 15, 2026 annual meeting, National Healthcare Properties, Inc. reported that shareholders representing about 50.42% of outstanding common stock were present in person or by proxy. Investors elected six directors, including Leslie D. Mich...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 06, 2026